In the search for a radioligand capable of imaging cannabinoid CB1 receptors in the living human brain by SPECT (single photon emission computed tomography), N-(morpholin-4-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM281) was synthesized. This compound is an analog of the potent, CB1 receptor selective antagonist 
INTRODUCTION
Marijuana is one of the oldest and most widely used drugs in the world. Although the pharmacological and biochemical properties of cannabinoids, the major psychoactive components of marijuana, have been studied extensively (1) their molecular mechanisms of action are not yet well understood.
Cannabinoid receptors have been the focus of much recent work, since the discovery of the receptor subtypes in brain (CB1) (2) and spleen (CB2) (3) . 
, a highaffinity and selective brain cannabinoid receptor antagonist, structurally related to the Sanofi compound SR141716A (4) (5) (6) (7) (8) , and its use to study cannabinoid receptor binding sites in mouse and rat brain (9, 10) . The distribution of cannabinoid receptor binding sites for [
123 I]AM251 in rat brain was very similar to the published distributions for the non-classical cannabinoid [ 3 H]CP-55,940 (11) (12) (13) . However, we were unable to visualize cannabinoid receptor binding sites in baboon brain with [ 123 I]AM251 by SPECT (single photon emission computed tomography) imaging because of negligible brain uptake in this species (9) . With the hypothesis that the inability to enter the brain may be associated with the high lipophilicity of AM251, we replaced the piperidine ring of AM251 with the more polar morpholino moiety. The k' values on reverse-phase high-performance liquid chromatography (HPLC) were 3.7 for AM281, 4.8 for SR141716A, and 5.7 for AM251, in agreement with the expectation that lipophilicity will increase upon replacing Cl with I, and decrease when replacing a piperidine group with a morpholine group. The resulting compound, AM 281 [N-(morpholin-4-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxamide], proved able to penetrate the baboon blood brain barrier and has been used in a preliminary study of cannabinoid CB1 receptors in the baboon brain (14) .
In the present article, we report details of the synthesis of AM281 (Scheme 1) together with further biological evaluation data.
Chemistry
The synthesis of
is outlined in Scheme 1. 4 -Bromo-propiophenone reacted with diethyl oxalate in anhydrous diethyl ether under basic conditions to afford the lithium salt of ethyl 2,4-dioxo-3-methyl-4-(4-bromophenyl) butanoate 1, which reacted with 2,4-dichlorophenylhydrazine hydrochloride to provide 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid ethyl ester 2. The procedure for the conversion of ester 2 to amide 3 via three steps in our earlier publication with AM251 (10) was now shortened to a single step in which ester 2 was allowed to react with 4-aminomorpholine under basic conditions. Subsequently, the bromo derivative 3 reacted with bis(tributyltin) in the presence of a catalytic amount of tetrakis(triphenylphosphine)palladium(0) to afford the tributyltin derivative 4. Iododestannylation of compound 4 by the method used previously (10) for preparation of AM251 involving sodium iodide and chloramine-T in the presence of either acetic acid or phosphoric acid gave the desired compound 5 in a low yield (15-21%), and the product was especially difficult to purify. The alternative method where the tributyltin compound 4 was allowed to react with iodine in a carbon tetrachloride solution (15) gave AM281 in almost quantitative yield.
Radiolabeling was conducted similarly to that of [ 123 I]AM251 (10) . The addition of a trace of carrier iodide, and use of SEP-PAK methodology instead of HPLC as the purification procedure, increased the net yield of AM281 from about 50% to about 75%, while resulting in a product of sufficiently high specific activity (about 5 Ci/µmol) to visualize CB1 receptors in vivo. 
BIOLOGICAL RESULTS AND DISCUSSION

Receptor Binding Studies of AM281 In Vitro
The affinity of AM281 for the cannabinoid receptor in rat forebrain membranes was evaluated using the competitive binding assay showed a K i value of 12 nM ( Figure 2 ). In contrast, AM281 had very low affinity for the CB2 cannabinoid receptor as measured in mouse spleen membrane preparation (K i value of 4200 nM). These results indicated that AM281 is a selective cannabinoid receptor ligand with a 340-fold selectivity for CB1 compared to CB2 receptors.
Antagonism Studies
At a concentration of 1 µM, AM281 produced a significant dextral shift in the log concentrationresponse curve of the cannabinoid receptor agonist, WIN55,212-2 ( Figure 3 ) (16). This shift was parallel and not accompanied by any change in the size of the maximal response to the agonist. The mean K d value of AM281 calculated from these data was 110 nM, the 95% confidence limits being 42 nM and 710 nM. The data suggest that AM281 shares the ability of SR141716A to behave as a competitive cannabinoid receptor antagonist in the myenteric plexus-longitudinal muscle preparation of guinea-pig small intestine (16) . We have also shown that AM281 behaves as a cannabinoid receptor antagonist in the electrically stimulated rat hippocampal slice model (17) .
Brain Imaging
The transaxial SPECT images confirmed uptake of radioactivity in cerebellum and in cortical areas ( Figure 4 ). The spatial resolution of current SPECT scanners is insufficient to permit visualization of the subcortical areas of highest CB1 receptor density, such as the substantia nigra and globus pallidus in the monkey brain. However, heterogeneous distribution of [ 123 I]AM281 was clearly seen in rat brain autoradiograms obtained using a phosphor imaging plate ( Figure 5 ). 
EXPERIMENTAL SECTION Chemistry
Melting points were determined using an Electrothermal melting point apparatus and are uncorrected. 1 H NMR spectra were recorded on a Brucker DMX-500 MHz spectrometer. Chemical shifts are reported in ppm (parts per million) relative to tetramethylsilane as the internal standard, and signals are quoted as s (singlet), d (doublet), t (triplet) or m (multiplet). Mass spectra (electron ionization, 70 eV) were determined on a KRATOS MS-50RFA instrument. Elemental analyses were performed at Analytical Services Center of Baron Consulting Company. Compounds indicated by the molecular formula followed by the symbols for the elements (C, H, N) were found to be within 0.4% of their theoretical values. The HPLC system was an Alltech Econosil cyanopropyl column (10-µ particles; 4.6 250 mm column length) eluted with acetonitrile/water (34:66, v/v) containing 25 mM ammonium acetate. Flash column chromatography was carried out by using Whatman active silica gel (230-400 mesh), and eluents were distilled before use. Solvents for reactions were dried or purified if necessary. Reactions were carried out under nitrogen atmosphere unless otherwise noted.
N-(Morpholin-4-yl)-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (3).
To a magnetically stirred solution of ester 2 (3.00 g, 6.60 mmol) and 4-aminomorpholine (772 µL, 7.90 mmol) in dry tetrahydrofuran (25 mL) was added 1.0 M solution of lithium bis(trimethylsilyl)amide in hexane (10.0 mL, 10.0 mmol). The resulting mixture was stirred at room temperature for 2 hours, and then quenched with saturated aqueous ammonium chloride and extracted with chloroform (3 50 mL). The combined extracts were washed with brine, dried over anhydrous sodium sulfate, filtered, and evaporated. Purification by flash column chromatography on silica gel with chloroform and ethyl acetate (1:1) afforded amide 3 as a white solid -4-yl)-1-(2,4-dichlorophenyl)-5-(4-tributyltinphenyl)-4-methyl-1H-pyrazole-3-carboxamide (4) . To a magnetically stirred suspension of 3 (2.40 g, 4.70 mmol) in fresh distilled triethylamine (150 mL) was added bis(tributyltin) (3.16 mL, 6.25 mmol) followed by tetrakis(triphenylphosphine)palladium (0) (272 mg, 0.23 mmol) at room temperature under an argon atmosphere and the reaction mixture was heated to reflux for 30 hours. After cooling to room temperature, the precipitate was removed by filtration. The filtrate was then concentrated under reduced pressure and purified by flash column chromatography on silica gel with petroleum ether and acetone (4:1) 
N-(Morpholin
Receptor Binding Assay
For CB1 receptor binding studies, rat forebrain membranes were prepared following earlier procedures (18, 19) . For CB2 receptor binding studies, membranes were prepared from frozen mouse spleen according to Dodd (20) . Silanized centrifuge tubes were used throughout to minimize receptor loss due to the adherent properties of the CB2 containing macrophages (18) . The binding of the novel probes to the cannabinoid receptors was assessed as previously described (18, 21) . Briefly, approximately 50 µg of rat forebrain or mouse spleen membranes were incubated in silanized 96-well microtiter plates with TME containing 0.1% essentially fatty acid free bovine serum albumin (BSA), 0.8 nM [
3 H]CP-55,940, and various concentrations of AM281 in a final volume of 200 µL. The assays were incubated for 1 hour at 30 o C and then immediately filtered on Unifilter GF/B filterplates using a Packard Filtermate 196 harvester, followed by four washes with ice cold wash buffer containing 0.5% BSA. Radioactivity was detected by adding MicroScint 20 scintillation cocktail directly to the dried filterplates, which were counted using a Packard Instruments TopCount Microplate Scintillation Counter. Nonspecific binding was assessed using 100 nM CP-55,940. Data collected from three independent experiments performed with duplicate determinations were normalized between 100 and 0% specific binding for [ 3 H]CP-55,940. The normalized data were then analyzed using a 4-parameter nonlinear logistic equation to yield IC 50 values. The IC 50 values from three independent experiments were combined and converted to K i values using the assumptions of Cheng and Prusoff (22) .
Pharmacological Studies In Vitro
The in vitro pharmacology of AM281 was investigated using the myenteric plexus-longitudinal muscle preparation of guinea-pig small intestine assay. The measured response was WIN55,212-2-induced inhibition of electrically evoked contractions (18, 19) . Both drugs were mixed with two parts of Tween 80 by weight and dispersed in a 0.9% aqueous solution of NaCl (saline). The size of maximal responses to WIN55,212-2 (E max values) and their 95% confidence limits were calculated by non-linear regression analysis using GraphPAD InPlot (GraphPAD Software, San Diego). The K d value of AM281 was calculated using the equation (x-1) = B/K d , where x (the "dose ratio") is the concentration of WIN55,212-2 that produces a particular degree of inhibition in the presence of the antagonist at a concentration, B, divided by the concentration of WIN55,212-2 that produces an identical degree of inhibition in the presence of Tween 80 (18, 19, 23, 24) . The dose ratio and its 95% confidence limits have been determined by symmetrical (2 + 2) dose parallel line assay (25) , using responses to pairs of WIN55,212-2 concentrations located on the steepest part of each log concentration-response curve.
Preparation of Radioiodinated AM281
Procedures were essentially as described for [
123 I]AM251 (10), except for the following. No carrier added [ 123 I]NaI was purchased in 20 mCi lots from Nordion (Kanata, Ont.) as the dried product in serum capped vials. To the shipping vial were added in turn with shaking between additions: sufficient water (about 100 µL) to dissolve the dried residue; 4 µL of a 1 mM aqueous solution of NaI; 50 µL of 0.5 M H 3 PO 4 ; 100 µL of a 1 mg/mL solution in DMSO of the tributyltin analog of AM281, sufficient ethanol (about 300 µL) to make a clear solution, and 20 µL of a 10 mg/mL aqueous solution of chloramine-T. The mixture was shaken, left to stand at room temperature for 3 min, and then mixed with 5 mL of water and passed through a SEP-PAK containing 300 mg octadecylsilane (Alltech Associates, Deerfield, IL). The SEP-PAK was washed in turn with 5 mL water and 3 mL 35% methanol. The radiolabeled product was eluted in 5 mL 70% methanol. The solvent was removed with a stream of N 2 with warming at 50 o C, and the residue was re-dissolved in 0.1 mL absolute ethanol.
Brain Imaging
A Picker 3000 camera, equipped with low energy ultra high resolution collimators, was employed for SPECT studies. A 128 128 acquisition matrix was used, and the energy peak was set at 158 keV with a 15% window. Image reconstruction was performed using the predefined brain SPECT protocol supplied with the camera. Transverse sections were reconstructed using a Butterworth filter. A 3-D post filter (low pass with order of 4.0 and cutoff 0.26) was then applied. Attenuation correction was performed using an ellipse fitting with a factor of 0.11. Transaxial images were obtained with a slice width of 8.6 mm. Using sterile techniques, the ethanolic solution of [ 123 I]AM281 was rapidly mixed with 2 mL of blood plasma prepared immediately beforehand from the experimental subject, and then diluted to 20 mL with 0.9% NaCl. One third of the saline solution was injected into the anesthetized baboon over about 1 min, and the remainder was infused over a 2-hour period while the animal was scanned. The distribution of [
123 I]AM281 in slide-mounted rat brain sections was visualized using a phosphor imaging plate (Molecular Dynamics, Sunnyvale, CA) essentially as previously described (14) .
